N acetylcysteine in paracetamol toxicity cats

I'll start by reading the medical library skill, then search for relevant content on N-acetylcysteine (NAC) in paracetamol (acetaminophen) toxicity in cats.
Reading File
Now let me search the library and PubMed in parallel for NAC in paracetamol toxicity in cats.
Finding Sources
Finding Sources
Searching PubMed

N-acetylcysteine paracetamol toxicity cats

Let me broaden the searches - trying different term combinations and searching the library for veterinary content.
Finding Sources
Finding Sources
Searching PubMed

acetaminophen toxicity cats feline

The library doesn't have veterinary toxicology content. Let me search for NAC use specifically, and also do a broader library search plus web search.
Finding Sources
Searching PubMed

N-acetylcysteine antidote feline hepatotoxicity

Searching the Web

N-acetylcysteine paracetamol acetaminophen toxicity cats dose protocol treatment

Excellent - I now have rich clinical information. Let me extract the pharmacokinetics paper from AVMA for dosing details.
Reading Web Page

https://avmajournals.avma.org/view/journals/ajvr/74/2/ajvr.7…

Searching PubMed

N-acetylcysteine pharmacokinetics cats acetaminophen

I now have comprehensive information to give a thorough answer. Let me compile everything.

N-Acetylcysteine (NAC) in Paracetamol (Acetaminophen) Toxicity in Cats

Why Cats Are Uniquely Susceptible

Cats are far more sensitive to paracetamol than dogs or humans because they have a deficiency of hepatic glucuronyl transferase (UDP-glucuronosyltransferase). In most mammals, paracetamol is safely conjugated with glucuronic acid and excreted. In cats, this pathway is severely limited, so a much greater proportion of the drug is shunted through cytochrome P450 (CYP2E1) to the toxic reactive metabolite NAPQI (N-acetyl-p-benzoquinone imine). NAPQI depletes hepatic glutathione, then binds to cellular proteins, causing:
  • Hepatocellular necrosis (centrilobular)
  • Methemoglobinemia - NAPQI oxidizes hemoglobin Fe²⁺ → Fe³⁺, impairing oxygen carriage
  • Heinz body hemolytic anemia - cats' hemoglobin is particularly susceptible to oxidative damage
  • Facial/paw edema - a hallmark sign in cats (less common in dogs)
Even a single human-strength tablet (500 mg) is potentially lethal to an average cat.

Clinical Signs in Cats

Time post-ingestionSigns
0-4 hoursVomiting, lethargy, anorexia, salivation
4-12 hoursFacial/paw edema (characteristic), cyanosis/brown mucous membranes (metHb), dyspnea
12-48 hoursJaundice (icterus), hepatic failure, coagulopathy
Biochemical findings: elevated ALT, markedly elevated total bilirubin, elevated BUN (reflecting hepatorenal damage), anemia with Heinz bodies, reduced PCV.

Mechanism of NAC Action

NAC (N-acetylcysteine) works through multiple complementary mechanisms:
  1. Glutathione precursor - NAC is deacetylated to cysteine, the rate-limiting substrate for glutathione synthesis. Replenishing glutathione allows hepatocytes to scavenge NAPQI.
  2. Direct sulfhydryl donor - NAC itself can conjugate NAPQI directly.
  3. Antioxidant - reduces oxidative stress on erythrocytes (helps reduce methemoglobinemia alongside ascorbic acid).
  4. Anti-inflammatory - reduces cytokine-mediated hepatic injury.

Dosing Protocol in Cats

The standard regimen used in clinical practice is adapted from human medicine, with important pharmacokinetic caveats (see below):
RouteLoading DoseMaintenance DoseFrequency
IV (Mucyst)140 mg/kg (Day 1, slow IV infusion)70 mg/kgq4-6h for 2-3 days
Oral140 mg/kg stat70 mg/kgq6h for 5-7 days
Standard protocol from case reports:
  • Day 1: NAC 140 mg/kg IV (loading)
  • Days 1-2: NAC 110-140 mg/kg IV daily
  • Discharge: Oral NAC 70 mg/kg twice daily for 5-7 days
Oral bioavailability is reasonable in cats, but IV is preferred initially for critically ill animals.

Important Pharmacokinetic Consideration

A key pharmacokinetics study published in the American Journal of Veterinary Research (AJVR, 2013) found that:
  • NAC has a shorter elimination half-life in cats than in humans, due to faster clearance.
  • The standard human protocol (maintenance every 6 hours) may not achieve therapeutic plasma concentrations in cats.
  • The AVMA study suggests maintenance doses should be given every 3 hours rather than every 6 hours for IV therapy in acute toxicosis.
  • To achieve the same area-under-the-curve (AUC) as the therapeutic human regimen, a constant-rate infusion (CRI) of approximately 40.5 mg/kg/h would be needed (vs. 23 mg/kg/h in humans).
This is clinically important: the widely cited "every 6-hour" protocol likely under-doses cats. The AJVR pharmacokinetics paper recommends re-evaluating dosing intervals for cats.

Adjunct Treatments

NAC alone is not sufficient - a full supportive protocol should include:
TreatmentDoseRationale
Activated charcoal1-2 g/kg PODecontamination if <2-4 hours post-ingestion
Ascorbic acid (Vit C)30-40 mg/kg IV/SC q6hReduces methemoglobin (metHb reductase cofactor)
IV fluids (Ringer's lactate / DNS)10 ml/kg IVHydration, hepatic perfusion
Sodium bicarbonateIf severe metHb acidosisAlkalinize urine
Antibiotics (Amoxicillin-Cloxacillin)12.5 mg/kg IV/POPrevent secondary infection in hepatic failure
Proton pump inhibitor (Pantoprazole)1 mg/kg IVGI protection
SAMe (S-adenosylmethionine)20 mg/kg/day POAdditional glutathione support
Hematinic supportAs neededFor hemolytic anemia
Note: Do NOT induce emesis in cats with paracetamol toxicity if respiratory distress or metHb is already present. Dexmedetomidine (oral/IM) is now the preferred emetic in cats if decontamination is still appropriate.

Treatment Timing

Early treatment is critical. NAC is most effective when given within 8-10 hours of ingestion. Beyond 24 hours, hepatic injury may be established, but NAC still has benefit through its anti-inflammatory and antioxidant effects on ongoing injury.

Key Points Summary

  • Cats lack glucuronidation capacity → massive NAPQI accumulation → hepatotoxicity + methemoglobinemia
  • NAC is the primary antidote - replenishes glutathione and directly conjugates NAPQI
  • Standard loading dose: 140 mg/kg IV, maintenance 70 mg/kg q4-6h
  • Pharmacokinetics data suggests cats may need q3h dosing (not q6h) due to faster NAC clearance
  • Always combine with ascorbic acid to treat methemoglobinemia
  • Prognosis is good with early treatment; fatal without intervention

Clinical cases cited: Sangamitra et al., 2021 | Sidhu et al., ISVM 2021 | AJVR pharmacokinetics 2013 | Savides & Oehme 1985 (PMID: 4026031)
This is a shared conversation. Sign in to Orris to start your own chat.